It's official: The Pfizer-AstraZeneca deal talk can resume

Let the speculation continue: The window to another Pfizer-AstraZeneca bidding round is now open, per U.K. takeover rules. As of Tuesday, AstraZeneca ($AZN) can legally invite Pfizer ($PFE) to negotiate a deal. Pfizer could make its own one-time-only offer in private. But Pfizer can't take it upon itself to rebid in public until November. And what are the chances that the hard-to-get AstraZeneca will volunteer for another dance with its U.S.-based rival? Report